1. All‐oral therapy with nucleotide inhibitors sofosbuvir and GS‐0938 for 14 days in treatment‐naive genotype 1 hepatitis C (NUCLEAR). Issue 10 (31st March 2013) Authors: Lawitz, E. J.; Rodriguez‐Torres, M.; Denning, J.; Mathias, A.; Mo, H.; Gao, B.; Cornpropst, M. T.; Berrey, M. M.; Symonds, W. T. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 10(2013) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗